Hemogenyx Pharmaceuticals Plc (LON: HEMO)
London
· Delayed Price · Currency is GBP · Price in GBX
1.200
-0.325 (-21.31%)
Nov 22, 2024, 6:56 PM BST
Hemogenyx Pharmaceuticals Market Cap
Hemogenyx Pharmaceuticals has a market cap or net worth of 16.10 million as of November 22, 2024. Its market cap has decreased by -42.42% in one year.
Market Cap
16.10M
Enterprise Value
17.20M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.20
Market Cap Chart
Since October 6, 2017, Hemogenyx Pharmaceuticals's market cap has increased from 10.68M to 16.10M, an increase of 50.75%. That is a compound annual growth rate of 5.92%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca PLC | 155.40B |
GSK plc | 53.19B |
Haleon plc | 33.23B |
Smith & Nephew plc | 8.62B |
ConvaTec Group PLC | 4.97B |
Hikma Pharmaceuticals PLC | 4.08B |
Oxford Nanopore Technologies plc | 1.20B |
Animalcare Group plc | 143.69M |